Impact of Clone Size With a Single Cytogenetic Abnormality on the Revised International Prognostic Scoring System in Myelodysplastic Syndromes

American Journal of Hematology - United States
doi 10.1002/ajh.25287
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Wiley

Related search

Cytogenetic Prognostic Factors in Myelodysplastic Syndromes

Hematology & blood transfusion: interdepartamental collection
2016English

Coalesced Multicentric Analysis of 2,351 Patients With Myelodysplastic Syndromes Indicates an Underestimation of Poor-Risk Cytogenetics of Myelodysplastic Syndromes in the International Prognostic Scoring System

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2011English

The Myelodysplastic Syndrome-Comorbidity Index Provides Additional Prognostic Information on Patients Stratified According to the Revised International Prognostic Scoring System

Haematologica
Hematology
2014English

Improving Revised International Prognostic Scoring System (IPSS-R) Pre-Allogeneic Stem Cell Transplant Does Not Translate Into Better Post-Transplant Outcomes for Patients With Myelodysplastic Syndromes: A Single Center Experience

Biology of Blood and Marrow Transplantation
TransplantationHematology
2018English

Bone Marrow Dyspoiesis and Revised International Prognostic Scoring System- A Comparative Study

Journal of Evolution of Medical and Dental Sciences
2019English

The 2016 Revised World Health Organization Definition of ‘Myelodysplastic Syndrome With Isolated Del(5q)’; Prognostic Implications of Single Versus Double Cytogenetic Abnormalities

British Journal of Haematology
Hematology
2017English

The Impact of Sex on Disease Phenotype and Prognostic Thresholds of Anemia in Myelodysplastic Syndromes

American Journal of Hematology
Hematology
2018English

Validation of a Prognostic Model and the Impact of Mutations in Patients With Lower-Risk Myelodysplastic Syndromes

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2012English

Cytogenetic Clonal Evolution in Myelodysplastic Syndromes Is Associated With Inferior Prognosis

Cancer
Cancer ResearchOncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy